Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity. Adam K, Lipatova Z, Abdul Ghafoor Raja M, Mishra AK, et al. J Immunol 2024;213:7-13.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Adam K, Lipatova Z, Abdul Ghafoor Raja M, Mishra AK, et al. Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity. J Immunol 2024;213:7-13.
PMID: 38775415